Evidence map›Paper›PMID 42182965›Full record

ArticleInternational journal of mass spectrometry2026

Impact of Supercharging on Top-Down Characterization of Monoclonal Antibodies by Collision Induced Dissociation.

Lasini Amunugama, Jared B Shaw

Abstract read
In one paragraph

Article in International journal of mass spectrometry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lasini AmunugamaDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, United States.
Jared B ShawDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE, United States.

Funding

Targeted mass spectrometry approaches to understand CART processing and recepter interactionsP20GM113126 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI GUO, JIANTAO · 2016 to 2025
$20.8M
Ion laboratory for the elucidation of macromolecular assembly heterogeneityR35GM157097 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI Jared Bryan Shaw · 2025 to 2026
$718k
NIGMS NIH HHS P20 GM113126NIGMS NIH HHS R35 GM157097
6 · The paper itself

Abstract

Native top-down characterization of monoclonal antibodies (mAbs) is an attractive approach due to the narrow charge state distribution of the intact mAb and the spectral decongestion afforded by relatively low charge product ions being spread over a broad m/z range. However, low precursor charge and extensive disulfide bonding together greatly limit characterization by collision induced dissociation (CID). This study evaluates solution phase supercharging in ammonium acetate electrospray solutions to produce charge state distributions with intermediate charge, i.e., somewhere between native and fully denatured. Sequence coverage and interchain disulfide bond cleavage were evaluated as a function of precursor charge and collision energy for denatured, native, and supercharged "native" mAb precursor ions. Native ESI produced low charge precursors (z~22-23) that required high collision energies (~200-225 eV/q) for interchain disulfide cleavages (i.e., light chain (LC) release) and yielded modest sequence coverage. Formic acid, 50:50 acetonitrile/water with formic acid, dimethyl sulfoxide, propylene carbonate, and sulfolane were compared as additives; many increased precursors charge states but produced broader envelopes and degraded spectral quality. In contrast 3% sulfolane in 100 mM ammonium acetate increased average charges to ~39 for Infliximab and ~42 for SigmaMAb and reduced the dissociation threshold to 125 eV/q as expected for higher charge precursor ions. Optimized conditions produced abundant [LC-S]/[LC]/[LC+S] triplets and extended b/y ions into CDR3 regions. Overall, adding 3% sulfolane in ammonium acetate provides a practical way to overcome key CID limitations for intact mAbs and enables more extensive sequence characterization.

Identifiers

PMID42182965
PMCPMC13196665

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.